Enzo Biochem, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

ENZ 2.91 -0.04 (-1.36%)
price chart
Enzo Biochem, Inc. Analyst Rating Update
Enzo Biochem, Inc. (NYSE:ENZ) shares are expected to touch $7 in the short term. This short term price target has been shared by 1 analysts.
Enzo Biochem Inc. (ENZ) is Trading Lower on Unusual Volume for June 12
Enzo Biochem Inc. (ENZ) experienced unusually high volume on Jun. 12, as the stock lost 0.66% to a closing price of $3.00. The stock saw 464,780 shares trade hands over the course of the day on 1,896 trades.
Company Shares of Enzo Biochem, Inc. Drops by -1.7%
Enzo Biochem, Inc. (NYSE:ENZ) has dropped 1.7% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 18.93% in the last 4 weeks.
Mid-Day Changers: CurrencyShares Japanese Yen Trust (FXY), New Jersey ...  WallStreet Scope
Company Shares of Enzo Biochem, Inc. Rally 1.35%
Shares of Enzo Biochem, Inc. (NYSE:ENZ) rose by 1.35% in the past week and 20% for the last 4 weeks. In the past week, the counter has outperformed the S&P 500 by 1.29% and the outperformance increases to 21.64% for the last 4 weeks.
Enzo Biochem Downgraded to "Sell" at Zacks (ENZ)  sleekmoney
Enzo Biochem Inc. (ENZ) is Trading Lower on Unusual Volume for June 10
Enzo Biochem Inc. (ENZ) experienced unusually high volume on Jun. 10, as the stock lost 1.61% to a closing price of $3.05. The stock saw 631,062 shares trade hands over the course of the day on 3,095 trades.
Enzo Biochem, Inc. Short Interest Increases by 4.9%  The Daily Rover
Enzo Biochem, Inc. (NYSE:ENZ) 3Q15 Revenue Up 4%
Dallas, Texas 07/02/2015 (Financialstrend) - Life sciences and biotech firm Enzo Biochem, Inc. (NYSE:ENZ) announced its third quarter 2015 operational results recently.
Enzo Biochem, Inc. v. Applera Corp. (Fed. Cir. 2010)
Enzo The '824, '767, '928, and '830 patents, which are owned by Plaintiffs-Appellants Enzo Biochem, Inc., Enzo Life Sciences, Inc., and Yale University ("Enzo"), are directed to various techniques for labeling and detecting nucleic acids. More ...
Enzo Biochem, Inc. Short Interest Update
Enzo Biochem, Inc. (NYSE:ENZ) ensharesed a rise of 11.6% or 223,270 shares in the short positions. The number escalated from 1,932,493 on May 29,2015 to 2,155,763 on June 15,2015.
Closing Bell Reports: Enzo Biochem Inc. (ENZ), KBR, Inc. (KBR), Gulfport ...  WallStreet Scope
Enzo Biochem, Inc. (NYSE:ENZ) is Expected to Report $-0.06
Enzo Biochem, Inc. (NYSE:ENZ) is expected to post current fiscal quarter earnings per share of $-0.06 when the company releases earnings later today, according to the consensus analyst numbers.
Tuesday's Pre-Market Info: Enzo Biochem Inc. (ENZ), Diageo plc (DEO ...  WallStreet Scope
Large Inflow of Money Witnessed in Enzo Biochem, Inc.
Enzo Biochem, Inc. (NYSE:ENZ) saw its share price trade relatively negative in the recent trading session. The share price was last updated to $2.99 with a loss of -0.02 points or -0.5%.